Literature DB >> 10971529

Re-evaluation of normative electronystagmography data in healthy ageing.

D Hajioff1, R M Barr-Hamilton, N R Colledge, S J Lewis, J A Wilson.   

Abstract

Previous work by our group questions the validity of existing electronystagmography (ENG) reference ranges in the elderly. We aim to establish valid reference ranges for ENG in people over 65 on the Nicolet Nystar Plus system. Ninety-six healthy asymptomatic subjects over 65 underwent ENG, including spontaneous and positional nystagmus, saccades, smooth pursuit, optokinetic nystagmus and bithermal calorics; 95% reference ranges with confidence intervals were calculated. The newly determined reference ranges were far wider than those provided by the ENG equipment manufacturer for eight out of 11 parameters (all P < 0.001). Vestibular function is known to deteriorate and become more variable with age. The failure to reflect this change in currently used reference ranges may have contributed to the high rates of vestibular disease reported in some series of dizzy elderly patients. Clinical interpretation of ENG depends on valid reference ranges.

Entities:  

Mesh:

Year:  2000        PMID: 10971529     DOI: 10.1046/j.1365-2273.2000.00361.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

1.  Aging of the Human Vestibular System.

Authors:  Christopher K Zalewski
Journal:  Semin Hear       Date:  2015-08

2.  Age related change of optokinetic nystagmus in healthy subjects: a study from infancy to senescence.

Authors:  C Valmaggia; A Rütsche; A Baumann; C Pieh; Y Bellaiche Shavit; F Proudlock; I Gottlob
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Effect of aging on saccular function.

Authors:  Mehri Maleki; Zahra Jafari; Homa Zarrinkoob; Alireza Akbarzadeh Baghban
Journal:  Med J Islam Repub Iran       Date:  2014-10-22

4.  Nystagmus characteristics of healthy controls.

Authors:  Allison S Young; Sally M Rosengren; Mario D'Souza; Andrew P Bradshaw; Miriam S Welgampola
Journal:  J Vestib Res       Date:  2020       Impact factor: 2.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.